Summary
A longitudinal study of lymphocytic infiltration in the endocrine pancreas of non-obese diabetic mice was performed to investigate the role of different lymphocyte subsets in the pathogenesis of diabetes. The incidence of insulitis and the percentage of mononuclear cell subsets in the pancreas were evaluated in non-obese diabetic mice of various ages (5, 9, 13, 17, 22, 29 and 36 weeks). Cryostat sections of pancreas were stained with heamatoxilin-eosin or with different monoclonal antibodies against total T lymphocytes, helper T lymphocytes, cytotoxic/suppressor T lymphocytes, activated interleukin 2 receptor positive lymphocytes and B lymphocytes. A monoclonal antibody against Class-II antigens was also used. Positive cells were revealed by the immunoperoxidase technique. Insulitis was found in 5 weeks old mice but to a lesser extent than in adult animals. No significant variation between infiltrating cell subsets was found in different age groups. T lymphocytes ranged between 20.4% and 28.1%, B lymphocytes between 28.8% and 30.8% and Class-II positive cells between 22.8% and 32.2%. Interleukin 2 receptor positive cells ranged between 5.5% and 8.5% as detected with AMT-13 monoclonal antibody which recognise the interleukin 2 binding site. A higher percentage of activated cells was observed using another monoclonal antibody (7D4) directed against a different epitope of the interleukin 2 receptor, suggesting the presence of activated lymphocytes with interleukin 2 receptors saturated by interleukin 2. No insulin-containing cells were found to express Class-II molecules as demonstrated by a double immunofluorescence technique. Most infiltrating mononuclear cells were found to be positive for Class-II and L3T4 antigens or to be Class-II positive and express surface immunoglobulins. We conclude that pancreatic infiltration is an early expression of autoimmune phenomena occurring in these mice and that monocytes and B-lymphocytes predominate in the infiltrate. The role of interleukin 2 and interleukin 2 receptor positive lymphocytes in inducing and maintaining the immune response towards B cells is discussed.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
References
Fujita F, Yui R, Kusumoto Y, Serizawa Y, Makino S, Tochino Y (1982) Lymphocytic insulitis in ‘Non-Obese Diabetic (NOD)’ strain of mice: an immunohistochemical and electron microscope investigation. Biomed Res 3: 429–443
Miyazaki A, Hanafusa T, Yamada K, Miyagawa J, Fujino-Kurihara H, Nakajima H, Nonaka K, Tarai S (1985) Predominance of T lymphocytes in the pancreatic islets and spleen of prediabetic non obese diabetic (NOD) mice: a longitudinal study. Clin Exp Immunol 60: 622–630
Hattori M, Buse JB, Jackson RA, Glimcher L, Dorf ME, Minami M, Makino S, Moriwaki K, Kuzuya H, Imura H, Strauss WM, Seidman JG, Eisenbarth GS (1986) The NOD mouse: recessive diabetogenic gene in the major histocompatibility complex. Science 231: 733–735
Prochazka M, Leiter EH, Serreze DV, Coleman DL (1987) Three recessive loci required for insulin-dependent diabetes in nonobese diabetic mice. Science 237: 286–289
Kanazawa Y, Komeda K, Sato S, Mori S, Akanuma K, Takaku F (1984) Non-Obese-Diabetic mice: immune mechanisms of pancreatic B-cell destruction. Diabetologia 27: 113–115
Pontesilli O, Carotenuto P, Gazda LS, Pratt PF, Prowse SJ (1987) Circulating lymphocyte populations and autoantibodies in nonobese diabetic (NOD) mice: a longitudinal study. Clin Exp Immunol 70: 84–93
Makino S, Harada M, Kishimoto Y, Hayashi Y (1986) Absence of insulitis and overt diabetes in athymic nude mice with NOD genetic background. Exp Anim 35: 495–498
Harada M, Makino S (1986) Suppression of overt diabetes in NOD mice by anti-thymocyte serum or anti-Thy 1,2 antibody. Exp Anim 35: 501–504
Bendelac A, Carnaud C, Boitard C, Bach JF (1987) Syngeneic transfer of autoimmune diabetes from diabetic NOD mice to healthy neonates. J Exp Med 166: 823–832
Wang Y, Hao L, Gill RG, Lafferty KJ (1987) Autoimmune diabetes in NOD mouse is L3T4 T-Iymphocyte dependent. Diabetes 36: 535–538
Shizuru JA, Taylor-Edwardd C, Banks BA, Gregory AK, Fathman CG (1988) Immunotherapy of the Nonobese Diabetic mouse: treatment with an antibody to T-helper lymphocytes. Science 240: 659–662
Momburg F, Koch N, Moller P, Moldenhauer G, Butcher G, Hammerling GJ (1986) Differential expression of Ia and Ia-associated invariant chain in mouse tissues after in vivo treatment with IFN-γ. J Immunol 136: 940–948
Osawa H, Diamenstein T (1984) A rat monoclonal antibody that binds specifically to mouse T lymphoblasts and inhibits IL2 receptor function: a putative anti-IL2r Ab. J Immunol 132: 2445–2450
Malek TR, Robb RJ, Shevach EM (1983) Identification and initial characterization of a rat monoclonal antibody reactive with the murine interleukin 2 receptor-ligand complex. Proc Natl Acad Sci USA 80: 5694–5698
Rowe DJ, Isemberg DA, Beverley PCL (1983) Monoclonal antibodies to human leukocyte antigens in polymyositis and muscolar dystrophy. Clin Exp Immunol 54: 327–336
Fujino-Kurihara H, Fujita H, Hakura A, Nonaka K, Tarui S (1985) Morphological aspects on pancreatic islets of non-obese diabetic (NOD) mice. Virchows Arch [Cell Pathol] 49: 107–120
Yale JF, Marliss EB (1984) Altered immunity and diabetes in the BB rat. Clin Exp Immunol 57: 1–11
Dean BM, Walker R, Bone AJ, Baird JD, Cooke A (1985) Prediabetes in the spontaneously diabetic BB/E rat: lymphocyte subpopulations in the pancreatic infiltrate and expression of rat MHC class II molecules in endocrine cells. Diabetologia 28: 464–466
Kataoka S, Satoh J, Fujiya H, Toyota T, Suzuki R, Itoh K, Kumagai K (1983) Immunologic aspects of the Nonobese Diabetic (NOD) mouse. Abnormalities of cellular immunity. Diabetes 32: 247–253
Pozzilli P, Sensi M, Al-Sakkaf L, Tarn A, Zuccarini O, Bottazzo GF (1984) Prospective study of lymphocyte subsets in genetically susceptible subjects to Type 1 diabetes. Diabetologia 27: 132–135
Tarn A, Dean BM, Thomas JM, Ingram D, Schewarz G, Bottazzo GF, Gale EAM (1988) Predicting insulin dependent diabetes. Lancet I: 845–850
Bottazzo GF, Dean BM, McNally JM, MacHay EH, Swift PGF, Gamble DR (1985) In situ characterization of autoimmune phenomena and expression of HLA molecules in the pancreas in diabetic insulitis. N Engl J Med 313: 353–360
Foulis AK, Liddle CN, Farquharson MA, Richmond JA, Weir RS (1986) The histopathology of the pancreas in Type 1 (insulin-dependent) diabetes mellitus: a 25 year review of deaths in patients under 20 years of age in United Kingdom. Diabetologia 29: 267–274
Signore A, Cooke A, Pozzilli P, Butcher G, Simpson E, Beverley PCL (1987) Class-II and IL2 receptor positive cells in the pancreas of NOD mice. Diabetologia 30: 902–905
Talle MA, Rao PE, Westberg E, Allegar N, Makowski M, Mittler RS, Goldstein G (1983) Patterns of antigenic expression on human monocytes as defined by monoclonal antibodies. Cell Immunol 78: 83–99
Flavell RA, Alien H, Burkly LC, Scherman DH, Waneck GL, Widera G (1986) Molecular biology of the H-2 histocompatibility complex. Science 233: 437–443
Araneo BA, Yowell RL (1985) MHC-linked immune responce suppression mediated by T cells bearing I-A-encoded determinants. J Immunol 135: 73–79
Lee K, Amano K, Yoon J (1988) Evidence for initial involvement of macrophage in the development of insulitis in NOD mice. Diabetes 37: 989–991
Kiesel U, Oschilewski M, Kantwerk G, Maruta M, Hanenberg H, Treichel U, Kolb-Bachofen V, Hartung HP, Kolb H (1986) Essential role of macrophages in the development of Type 1 diabetes in BB rats. Transplant Proc 18: 1525–1527
Kolb H, Zielasek J, Treichel U, Freitag G, Wrann M, Kiesel U (1986) Recombinant interleukin 2 enhances spontaneous insulin-dependent diabetes in BB rats. Eur J Immunol 16: 209–212
Kelley VE, Gaulton GN, Hattori M, Ikegami H, Eisenbarth G, Strom TB (1988) Anti-interleukin 2 receptor antibody suppresses murine diabetic insulitis and lupus nephritis. J Immunol 140: 59–61
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Signore, A., Pozzilli, P., Gale, E.A.M. et al. The natural history of lymphocyte subsets infiltrating the pancreas of NOD mice. Diabetologia 32, 282–289 (1989). https://doi.org/10.1007/BF00265543
Received:
Revised:
Issue Date:
DOI: https://doi.org/10.1007/BF00265543